PVTT.F Stock Overview
Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Pivotal Therapeutics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0018 |
| 52 Week High | US$0.0021 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -75.34% |
| 5 Year Change | -48.57% |
| Change since IPO | -99.36% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PVTT.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | n/a | 13.1% | 30.7% |
Return vs Industry: Insufficient data to determine how PVTT.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how PVTT.F performed against the US Market.
Price Volatility
| PVTT.F volatility | |
|---|---|
| PVTT.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PVTT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PVTT.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Rachelle MacSweeney | www.pivotaltherapeutics.us |
Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels.
Pivotal Therapeutics Inc. Fundamentals Summary
| PVTT.F fundamental statistics | |
|---|---|
| Market cap | US$172.43k |
| Earnings (TTM) | -US$2.77m |
| Revenue (TTM) | US$269.82k |
0.0x
P/S Ratio0.0x
P/E RatioIs PVTT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PVTT.F income statement (TTM) | |
|---|---|
| Revenue | CA$356.99k |
| Cost of Revenue | CA$385.17k |
| Gross Profit | -CA$28.17k |
| Other Expenses | CA$3.64m |
| Earnings | -CA$3.67m |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PVTT.F perform over the long term?
See historical performance and comparison